Analysts at Cowen assumed coverage on shares of Acrivon Therapeutics (NASDAQ:ACRV – Get Rating) in a research note issued on Monday, The Fly reports. The brokerage set an “outperform” rating on the stock. Separately, Piper Sandler started coverage on shares of Acrivon Therapeutics in a report on Sunday. They set an “overweight” rating and a […]
